IL6 and Crohn disease: Resveratrol has been shown to reduce the levels of proinflammatory mediators such as interleukin 1β (IL-1β), interleukin 6 (IL-6), TNF-α, and TGF-β1 in a rat model of Crohn’s disease [66].